Highlights of Multiple Myeloma Research Presented at ASH With Urvi Shah, MD

At the recent American Society of Hematology (ASH) Annual Meeting, numerous updates were presented with the potential to impact practice in relapsed/refractory multiple myeloma. While at the meeting, Urvi Shah, MD, Assistant Attending in the Myeloma Service at Memorial Sloan Kettering Cancer Center, shares some of most significant highlights of the clinical trials and therapeutic agents being presented. After listening to the podcast, be sure to watch Dr. Shah's free CME activity or book a live meeting for your institution to hear more expert perspectives on new directions in multiple myeloma treatment!

Free CME activity: https://www.i3health.com/course-information/expert-guidance-on-current-standards-and-new-directions-in-newly-diagnosed-multiple-myeloma

Book a meeting for your institution: https://www.i3health.com/live/expert-guidance-on-current-standards-and-new-directions-in-newly-diagnosed-multiple-myeloma-1